Gordon K, Warren RB, Gottlieb AB, Blauvelt A, Tha?i D, Poulin Y, Boehnlein M, Brock F, Arendt C, Reich K. Durable Efficacy of Certolizumab Pegol Dosed at 400 mg Every Two Weeks Over 128 Weeks in Patients with Plaque Psoriasis Enrolled in Three Phase 3 Trials (CIMPASI-1, CIMPASI-2 and CIMPACT). J of Skin [Internet]. 2020 Sep. 2 [cited 2024 Jul. 3];4(5):s45. Available from: https://jofskin.org/33014/index.php/skin/article/view/994